Hoji Alimi, one of our founders, served as our chief executive officer, president and director since 1999 and was appointed as chairman of the board of directors in June 2006. Prior to co-founding our company with his spouse in 1999, Mr. Alimi was a corporate microbiologist for Arterial Vascular Engineering. Mr. Alimi received a B.A. in biology from Sonoma State University.
Jay Birnbaum Jay Birnbaum has served as a director since April 2007. Dr. Birnbaum is a pharmacologist and previous to his current role as a consultant to pharmaceutical companies, he served as vice president of global project management at Novartis/Sandoz Pharmaceuticals Corporation, where he had responsibility for strategic planning and development of the company's dermatology portfolio. Dr. Birnbaum is a co-founder of Kythera Biopharmaceuticals, a company developing products in aesthetic and restorative dermatology, as well as a member of NanoBio Corporation's scientific advisory board. He received both an M.S. and Ph.D. in pharmacology from the University of Wisconsin and a B.S. in biology from Trinity College in Connecticut.
Richard Conley Richard Conley has served as a director since 1999, and served as our secretary from July 2002 to June 2006. Since April 2001, Mr. Conley has served as executive vice president and chief operating officer at Don Sebastiani & Sons International Wine Negociants, a branded wine marketing company. From 1994 to March 2001, he served as senior vice president and chief operating officer at Sebastiani Vineyards, a California wine producer, where he was originally hired as chief financial officer in 1994. Mr. Conley received a B.S. in finance and accounting from Western Carolina University and an M.B.A. from St. Mary's University.
Greg French Gregory French has served as a director since 2000. Mr. French is owner and chairman of the board of G&C Enterprises LLC, a real estate and investment company, which he founded in 1999. He held various engineering and senior management positions at several medical device companies, including Advanced Cardiovascular Systems, Peripheral Systems Group and Arterial Vascular Engineering. Mr. French received a B.S.I.E. from the California State Polytechnic University, San Luis Obispo.
Jim Schutz James Schutz, chief operating officer, also has served as vice president of
corporate development and general counsel since August 2003, as a director since May 2004 and corporate secretary since June 2006. From August 2001 to August 2003, Mr. Schutz served as general counsel at Jomed (formerly EndoSonic Corp.), an international medical device company. From 1999 to July 2001, Mr. Schutz served as in-house counsel at Urban Media Communications Corporation, an Internet/telecom company based in Palo Alto, California. Mr. Schutz received a B.A. in economics from the University of California, San Diego and a J.D. from the University of San Francisco School of Law.
Jerry McLaughlin has served as a director since March 2013. Mr. McLaughlin has served as interim CEO of Applied BioCode, Inc., an emerging molecular diagnostic company, since November 2011. He also founded and currently serves as president and CEO of DataStream Medical Imaging Systems, Inc., which develops diagnostic imaging software applications that work in conjunction with existing digital radiology platforms. He previously served as president of DataFlow Information Systems, from July 2007 to December 2011, and president and CEO of CompuMed, Inc. from May 2002 to June 2007. He received a BS in pharmacy from the State University of New York at Buffalo.